#EXP00159

General

Accession EXP00159
Activity Preformed biofilm
Date 2013-11-26
Administration In solution
Model in vitro
Organism Pseudomonas aeruginosa
Status Validated
Notes Pa9 clinical isolate

Peptide

BMAP-27

GRFKRFRKKFKKLFKKLSPVIPLLHL

Experimental activity

Method Concentration Notes
Total countable CFUs 1.241 uM No notes
Crystal violet assay 6.203 uM No notes

References

Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients

A. Pompilio, M. Scocchi, S. Pomponio, F. Guida, A. Di Primio, E. Fiscarelli, R. Gennaro, G. Di Bonaventura

2011. Peptides 9:1807-1814